Digital Health

Cybersecurity
- Uncategorized
Digital patient management
Digital policy & regulation
Healthcare Innovation
ICT and Health
Tech & Pharma
Tech companies & Data

Text search

Sort by Price

Click to order products ascending

Display 15 Products per page

Pharma Intelligence Report Store Article Collection Innovation, Data and Machine Learning Report 2

$500.00

OTC drug firms should offer more digital tools that guide consumers in product purchases, says a health care marketing executive. The American Pharmacists Association suggests firms also strengthen outreach with pharmacists.
March 16, 2017
Find out more
Mail Order and Internet Pharmacy in Europe

$740.00

This 17-country study finds that continued growth of mobile technologies and e-commerce,combined with a more stable regulatory environment, are driving changes in the European mail order and Internet pharmacy market.
January 18, 2017
Find out more
Wearables are Transforming R&D and Care Delivery

$2,995.00

Wearable technologies have the potential to transform medicine and the delivery of healthcare more significantly than any other component of the digital revolution – or indeed than many other scientific advances.
June 6, 2016
Find out more
Data in Healthcare: Underpinning the Shift to Value

$2,995.00

Data plays a key role in healthcare systems’ shifts towards value-focused outcomes. Such data includes outcomes and cost data, adherence data, and increasingly, patient-reported data, behavioral and social media data.
November 23, 2016
Find out more
Transforming Pharmaceutical R&D with Data

$2,995.00

Ongoing pressures on drug pricing and reimbursement mean that current research and development (R&D) economics are unsustainable. The process of discovering and developing a drug has not fundamentally changed for decades, and on average it still costs $2.6bn and takes over 10 years. Fortunately, tools are emerging to help improve R&D success rates. Most are built on better use of more kinds of data, including using artificial intelligence (AI) to process massive quantities of information that humans cannot manage. Some of these new tools promise cost and time savings of between 20–50%
May 2, 2017
Find out more
The Intersection Between Tech and Pharma Special Report (Part 2. Apple)

$3,000.00

In January 2015, Fortune reported that at $2.9tn, the state of the US healthcare industry is very strong and continues to grow. Additionally, a Top Issues report revealed that 40% of Fortune 50 companies pursued new healthcare partnerships in 2014. Given the rapid change in the healthcare industry over the last few years, it is no surprise that we are starting to see more non-traditional healthcare partnerships, specifically with big tech companies.
January 14, 2016
Find out more
The Intersection Between Tech and Pharma Special Report (Part 3. Intel, Samsung, IBM, and GE)

$3,000.00

The Intersection Between Tech and Pharma Special Report (Part 3. Intel, Samsung, IBM, and GE)
January 22, 2016
Find out more
Special Report: The Intersection Between Tech and Pharma (Part 1. Google)

$3,000.00

In January 2015, Fortune reported that at $2.9tn, the state of the US healthcare industry is very strong and continues to grow.
January 2, 2016
Find out more
Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Systems

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and AVM embolization systems. This market comprises the following product segments: endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel/emerging embolization devices. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets. The forecast range for this report is 2020–25.
December 16, 2021
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *